A new approach to restore lung function and reduce antibiotic resistance Read More

Disrupting bacterial biofilms and mucus to alter the progression of pulmonary diseases

View our Pipeline

Developing a new class of
glycopolymer-based therapeutics
that target key drivers
of pulmonary decline Read More


November 02, 2017

Synspira Announces Data for Lead Candidate at the 31st Annual North American Cystic Fibrosis Conference

Pre-clinical results demonstrate reduction in pulmonary inflammation and infection as well as mucus clearing by SNSP113

Read More

A breath of fresh air in the treatment of lung disease.